Disclosed CapitolDisclosedCapitol
Home
Plans
Chad AI
API
Sign InGet Pro

Never Miss a Trade

Get weekly trade alerts free.

Explore

  • Politician Trades
  • Politicians
  • Executive Branch
  • Companies
  • All Stocks A–Z
  • Leaderboard
  • Compare Politicians
  • Committee Portfolios
  • Chad AI

Money & Policy

  • Government Contracts
  • Lobbying
  • Legislation
  • Campaign Finance
  • Institutional (13F)
  • Whale Watch (13D)

Markets

  • Markets Overview
  • Top Companies
  • Insider Trends
  • Economic Indicators
  • Live News

Resources

  • API Access
  • Developers
  • Developer Guides
  • Data Export
  • Glossary
  • Methodology
  • Data Sources
  • How It Works

Company

  • About Us
  • Press
  • FAQ
  • Pricing
  • vs. Capitol Trades
  • Contact
  • Watchlist

Legal

  • Editorial Standards
  • Corrections
  • Disclaimers
  • Privacy
  • Terms
© 2026 Disclosed Capitol. All rights reserved.
TermsPrivacyDisclaimer
HomeTrades
Chad
WatchlistAccount
All news
PERFORMANCEoutperformer

Khanna McClain Filings Deliver Up to 484 Percent Post-Disclosure

Chad
·Thursday, November 19, 2026

Congressional trading disclosures continue to reveal a set of buys that delivered substantial gains after entering the public record. These returns are measured from the DISCLOSURE date forward and the public could have seen each of these positions when they were filed. The latest performance scan identifies six verified trades from four members that have returned between 187.02 and 484.06 percent since those filing dates.

Rep. Ro Khanna disclosed a purchase of MRNA on January 6, 2026. The position has returned 484.06 percent since disclosure. The California Democrat also filed a buy in MU on November 6, 2025 that has since returned 457.22 percent. Both trades sit in sectors that experienced strong momentum after the filings became available.

Rep. Lisa McClain recorded two standout buys. Her SNDK purchase, disclosed November 21, 2025, has returned 462.52 percent. The Michigan Republican's ROIV filing on August 13, 2025 shows a 250.36 percent gain since that date. McClain's healthcare-focused trade in ROIV and technology play in SNDK both outperformed broad benchmarks on a post-disclosure basis.

Additional positions include Rep. Tim Moore's TZA buy disclosed July 9, 2025, which has returned 330.44 percent, and Rep. Gilbert Cisneros's SEI purchase disclosed June 6, 2025 with a 187.02 percent return since filing. These examples span roughly 500 to 700 days held and demonstrate positive alpha ranging from 154 to 456 points relative to the market. The four members collectively focused on healthcare and technology names, with one leveraged small-cap instrument also appearing among the verified outperformers.

The data highlights how reviewing House and Senate filings promptly can surface positions with notable subsequent performance, though results vary widely and past patterns do not predict future moves. With distinct members from both parties participating, the set offers a window into areas where disclosed activity aligned with later market developments. This remains a selective snapshot of trades meeting the outperform threshold.

This is data analysis, not financial advice.

Mentioned in this article

MRNASNDKMUTZAROIVSEIRo KhannaLisa McClainTim MooreGilbert Cisneros

This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.